CIK 0001833141 · <br>Emerging growth company
Helus Pharma Inc.
Sign in to watch- Ticker
- HELP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- British Columbia, Canada
- Entity type
- other
- Phone
- (908) 764-8385
- Business address
- 100 KING STREET WEST, SUITE 5600, TORONTO, Ontario, Canada
- Former names
- CYBIN INC.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 4 Grant or award Director acquired 248,000 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 3,000 shares at $12.91 ($38,730)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Growth Officer acquired 248,000 shares (grant or award)
Page 1 of 23 · 454 filings